Overview

• Press Secretary Karoline Leavitt signaled an announcement today, posting that the unveiling would happen at the White House.
• Reporting describes TrumpRx as a direct-to-consumer website that would sell certain medications at lower cash prices.
• Key details remain unclear, including which drugs would be available and how transactions would be handled.
• A source cited by the Wall Street Journal, as relayed by The Mirror, links Pfizer to planned U.S. price reductions connected to the rollout.
• The expected announcement coincides with a public campaign warning about acetaminophen risks, including an FDA commissioner letter and statements by President Trump and HHS Secretary Robert F. Kennedy Jr. that many medical experts dispute.